
Sign up to save your podcasts
Or


Katie and Matt discuss tariffs, skeptical questions, nondelegation, major questions, reimbursement, the Metsera deal, amylin targeting, Sam Bankman-Fried’s appeal, alleged fraud at First Brands, factoring due diligence, the blockchain and short memories in the credit market.
See omnystudio.com/listener for privacy information.
By Bloomberg4.8
379379 ratings
Katie and Matt discuss tariffs, skeptical questions, nondelegation, major questions, reimbursement, the Metsera deal, amylin targeting, Sam Bankman-Fried’s appeal, alleged fraud at First Brands, factoring due diligence, the blockchain and short memories in the credit market.
See omnystudio.com/listener for privacy information.

977 Listeners

406 Listeners

1,173 Listeners

2,175 Listeners

1,993 Listeners

427 Listeners

355 Listeners

2,461 Listeners

943 Listeners

970 Listeners

797 Listeners

196 Listeners

289 Listeners

208 Listeners

30 Listeners

435 Listeners

355 Listeners

4 Listeners

155 Listeners

58 Listeners

233 Listeners

230 Listeners

69 Listeners

87 Listeners

81 Listeners

85 Listeners

194 Listeners

19 Listeners

14 Listeners

7 Listeners

2 Listeners

119 Listeners